Quit Smoking and Depression: Understanding the Connection
Many people with depression fear that quitting smoking will make their mental health worse. It is a reasonable concern — smoking often feels like self-medication, a reliable way to briefly lift mood during a difficult day. But the science on the relationship between quit smoking and depression is clear and encouraging: long-term, quitting smoking significantly improves depression, with effects comparable to antidepressant medication.
Understanding why this counterintuitive truth holds — and how to navigate the difficult transitional period — makes all the difference for smokers who are living with depression and wondering whether cessation is realistic for them.
How Smoking and Depression Are Linked
The relationship between smoking and depression runs in multiple directions:
Smoking Causes Depression Symptoms
Chronic nicotine use disrupts serotonin production — the neurotransmitter most directly associated with mood regulation and depression. Between cigarettes, as nicotine levels drop, serotonin and dopamine both decline, creating symptoms that closely resemble depression: low mood, anhedonia (inability to feel pleasure), fatigue, and difficulty concentrating.
Smokers experience this multiple times per day and typically attribute the low periods to their life circumstances rather than recognizing them as nicotine withdrawal. The next cigarette temporarily restores serotonin and dopamine — creating the illusion that smoking manages mood, when it is actually causing the mood disruption it appears to treat.
Depression Increases Smoking Risk
People with depression are significantly more likely to smoke than the general population. Rates of smoking among people with clinical depression are roughly twice the population average. The reasons are complex — nicotine’s short-term mood elevation is genuinely experienced as relief by people with low baseline mood, creating a powerful reinforcement cycle.
Shared Neurobiological Mechanisms
Depression and nicotine addiction share some underlying neurobiology — particularly involving dopamine and serotonin systems. This is why bupropion (Wellbutrin), an antidepressant, is also an approved smoking cessation medication. The same neural pathways are involved in both conditions.
What Happens to Mood in Early Withdrawal
In the first two to four weeks after quitting, mood disruption is real. The dopamine and serotonin deficits created by nicotine withdrawal produce symptoms that can include:
- Increased irritability and frustration
- Low mood and mild depressive symptoms
- Heightened anxiety (see our companion article on Nicotine Addiction and Anxiety)
- Difficulty concentrating
- Reduced motivation
- Sleep disruption
For someone with pre-existing depression, this transitional period can feel particularly difficult. The fear is that cessation will tip already challenging depression into something more serious.
Research does acknowledge this concern: a study published in ScienceDirect found that smoking cessation increases short-run mental distress. But the same research confirms that this short-run distress is followed by significant long-term improvements — specifically, reduced milder forms of long-run distress and measurable decreases in depression and anxiety by weeks nine to twenty-four.
The Long-Term Mental Health Evidence
The evidence on long-term mental health outcomes after quitting is among the most encouraging in cessation research. A meta-analysis of 26 studies cited by the University of Oxford found:
- Significant reductions in depression scores after cessation
- Significant reductions in anxiety
- Reduced perceived stress
- Improved positive mood and quality of life
- Effect sizes comparable to antidepressant medication
A separate large study published in JAMA Network Open specifically examined cessation outcomes in people with anxiety disorders and depression. The result: smoking abstinence between weeks nine and twenty-four was associated with significant improvements in both anxiety and depression scores. This held across people with diagnosed mental health conditions — not just the general population.
Research from ScienceDirect on the motivational dimension found that people with anxiety and depression who were told about the mental health benefits of quitting showed greater motivation to quit than those told only about physical health benefits. The mental health message is more compelling for this population — and it has the strongest evidence behind it.
Can You Quit If You Have Depression?
Yes. Contrary to widespread belief — including among healthcare providers — people with depression can and do successfully quit smoking. The cessation rates in people with mental health conditions are lower than the general population, but this reflects lack of appropriate support, not inability. When people with depression receive adequate cessation support, their quit rates are comparable to those without mental health conditions.
Research challenges the clinical assumption that mental health conditions should delay cessation attempts. A comprehensive review found that communicating the mental health benefits of quitting to people with depression or anxiety significantly increased motivation to quit. The message to take from this: depression is not a reason to postpone quitting — it is a reason to ensure adequate support is in place when you do.
Strategies for Quitting With Depression
1. Talk to Your Doctor First
If you have depression, involve your healthcare provider in your quit plan. They can monitor your mental health during the transition, adjust any existing antidepressant medication if needed, and discuss cessation medications that serve dual purposes.
2. Consider Bupropion
Bupropion (Wellbutrin/Zyban) is both an antidepressant and an approved smoking cessation medication. For smokers with depression, it addresses both conditions simultaneously — managing withdrawal mood disruption while supporting long-term mood stability. Discuss with your doctor whether this is appropriate for your specific situation.
3. Communicate the Mental Health Benefits
Research shows that framing cessation as a mental health intervention — not just a physical health one — is more motivating for people with depression. Your quit journey is not just about reducing cancer risk. It is about emerging from the nicotine-anxiety-depression cycle into a neurochemical baseline that genuinely supports better mental health.
4. Use CBT-Based Cessation Support
Cognitive Behavioral Therapy is effective for both depression and smoking cessation. App-based CBT tools — craving management, thought challenging, mood monitoring — deliver this support in accessible, daily-use form. The iQuit app incorporates these behavioral tools into a comprehensive cessation support system.
5. Build Extra Support During the First Four Weeks
The most difficult mood period is weeks one to four. Plan for extra social support, reduced major stressors where possible, and regular check-ins with your doctor during this window. The evidence says the investment pays off enormously beyond this transitional period.
Depression Is Not a Barrier to Quitting
The iQuit app provides behavioral support, mood tracking, and craving management tools that help you navigate the transition from smoking to better mental health.
Frequently Asked Questions
Does quitting smoking make depression worse?
In the short term — the first two to four weeks — mood disruption and some worsening of depressive symptoms can occur during nicotine withdrawal. This is a real and documented phenomenon. However, long-term, the evidence consistently shows that quitting smoking significantly improves depression. A meta-analysis of 26 studies found reductions in depression after cessation with effect sizes comparable to antidepressant medication. The short-term difficulty gives way to long-term mental health improvement.
Can people with clinical depression successfully quit smoking?
Yes. While people with depression have historically had lower cessation rates, research shows this reflects inadequate support rather than an inability to quit. When people with depression receive appropriate cessation support — including medication options like bupropion, behavioral therapy, and monitoring — their quit rates are comparable to the general population. Depression is not a barrier to successful cessation; it is an argument for more comprehensive support.
What is the best cessation medication for people with depression?
Bupropion (Wellbutrin/Zyban) is particularly suitable for smokers with depression because it is both an antidepressant and an approved cessation medication. It addresses withdrawal mood disruption directly. Varenicline is highly effective for cessation in general and is not contraindicated for depression — early concerns about psychiatric side effects have been substantially addressed by subsequent large studies. NRT is safe for everyone, including those with depression. Your doctor can recommend the best approach for your specific history and current medications.
How long until mood improves after quitting smoking?
Research shows that mood improves significantly between weeks nine and twenty-four after quitting. The first two to four weeks are the most challenging. Weeks four to eight show gradual improvement as brain dopamine and serotonin function normalizes. From week nine onward, most ex-smokers report mood at or better than their smoking baseline. The three-month mark is when dopamine function is fully normalized, which corresponds to the period most people report feeling genuinely better in their mental health.
Is it true that quitting smoking has the same effect as antidepressants on depression?
The research uses the phrase “comparable effect sizes” — meaning the magnitude of depression improvement observed in studies of smoking cessation is statistically similar to the improvement seen in antidepressant medication trials. This does not mean cessation replaces antidepressants or should be used as a substitute for needed psychiatric care. But it does indicate that cessation is a powerful mental health intervention in its own right, with genuine, clinically meaningful mood benefits that are often overlooked in discussions of why to quit.